Proposed NCATS has scientists hissing at plan to dismantle NIH resource centre
This article was originally published in Scrip
The fur has been flying at the US National Institutes of Health (NIH) ever since its director, Dr Francis Collins – the scientist who headed the US human genome project – decided last year that it was time to get serious about putting the agency's resources to greater use in translating basic discoveries into drug therapies, and proposed creating a new centre to do just that.
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.